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Supplememtary Figure S1 . The impact of CTA and CTS 1 on cell viability and metabolic integrity of human cells. HeLa cells cultivated in 48-well plates were co-transfected with 250ng pSEAP2-Control (P SV40 -SEAP-pA) and 50 -250 ng of (A) pMX43 (P SV40 -CTA-pA) or (B) pMX34 (P hEF1α -CTS 1 -pA). Cell viability (top panel) and SEAP expression (bottom panel) were scored in the culture supernatant after 48 h. The data are show as the mean ± SD, n = 3.
Supplementary Figure S2 . Antagonistic dual-input control of CTA/P CTA-O2 in vivo. In total, 2x10 6 pMX43/pMX38-transgenic microencapsulated HeLa cells (10,000 capsules, 200 cells/capsule) were intraperitoneally implanted into mice that either drank 4 x 200 µL sodium benzoate-containing H 2 O (total daily intake: 0 mg/kg (CTA), 1000 mg/kg (BA)) or received (2 x 100 µL) of vanillic acid (total daily intake: 500 mg/kg VA). The SEAP levels in the bloodstream of the treated animals were profiled after 24 h. The data are shown as the mean ± SEM, n = 6 mice.
